[Updated on Apr. 18] Integration of CiNii Articles into CiNii Research

Guidelines for Management of Atopic Dermatitis

  • Furue Masutaka
    Department of Dermatology, Fuculty of Medical Sciences, Kyushu University
  • Saeki Hidehisa
    Department of Dermatology, Graduate School of Medicine, University of Tokyo
  • Furukawa Fukumi
    Department of Dermatology, Wakayama Medical University
  • Hide Michihiro
    Department of Dermatology, Hiroshima University Graduate School of Biomedical Sciences
  • Ohtsuki Mamitaro
    Department of Dermatology, Jichi Medical University
  • Katayama Ichiro
    Department of Dermatology, Osaka University, Graduate School of Medicine
  • Sasaki Rikako
    Rikako's Clinic of Dermatology
  • Suto Hajime
    Department of Dermatology, Juntendo University, School of Medicine
  • Takehara Kazuhiko
    Department of Dermatology, Angiogenesis and Connective Tissue Metabolism, Kanazawa University Graduate School of Medicine

Bibliographic Information

Other Title
  • アトピー性皮膚炎診療ガイドライン
  • 日本皮膚科学会ガイドライン アトピー性皮膚炎診療ガイドライン
  • ニホン ヒフ カガクカイ ガイドライン アトピーセイ ヒフエン シンリョウ ガイドライン

Search this article

Abstract

Standard guideline for management (diagnosis, severity scoring and therapy) of atopic dermatitis (AD) is established. In this guideline, the necessity of dermatological training is emphasized in order to assure the diagnostic skill and to enable to evaluate the severity of AD. The present standard therapies for AD consist of the use of topical steroids and tacrolimus ointment for inflammation as well as emollients for dry and barrier-disrupted skin as the first-line topical applications, systemic anti-histamines and anti-allergic drugs for pruritus, avoidance of apparent exacerbating factors, psychological counseling, and advice about daily life. Tacrolimus ointment (0.1%) and its low density ointment (0.03%) are available for adult patients and 2-15 year old patients, respectively. The importance of correct selection of topical steroids according to the severity of the lesion is also emphasized. Deliberate use of oral cyclosporine for severe recalcitrant adult AD is also referred.

Journal

Citations (34)*help

See more

References(65)*help

See more

Related Articles

See more

Related Data

See more

Related Books

See more

Related Dissertations

See more

Related Projects

See more

Related Products

See more

Details

Report a problem

Back to top